UPDATED Jun 14, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VRRM | US$25.58 | -0.9% | 35.3% | US$4.3b | US$26.83 | PE52.2x | E29.7% | n/a | Commercial Services | ||
PEN | US$187.78 | -0.6% | -44.3% | US$7.3b | US$270.83 | PE77.9x | E26.2% | n/a | Healthcare | ||
AGX | US$76.80 | 0.6% | 93.1% | US$1.0b | US$77.50 | PE26.9x | E24.9% | 1.6% | Capital Goods |